Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Giuseppina Astone"'
Autor:
Francesca Ferrera, Almalina Bacigalupo, Fabiola Incandela, Francesca Costabile, Simone Negrini, Gilberto Filaci, Raffaele De Palma, Daniela Fenoglio, Sara Vlah, Stefania Vecchio, Alessandro Ascoli, Renzo Corvò, Alessio Signori, Giuseppina Astone, Alessia Parodi, Giorgio Peretti, Francesco Missale, Guido Schenone, Liliana Belgioia, Tiziana Altosole, Alison Tarke
Publikováno v:
Cancers
Volume 13
Issue 9
Cancers, Vol 13, Iss 2234, p 2234 (2021)
Volume 13
Issue 9
Cancers, Vol 13, Iss 2234, p 2234 (2021)
Simple Summary CD8+ T lymphocytes are among the immune cells reputed to kill tumor cells. Head and neck squamous cell carcinoma (HNSCC) has a poor clinical outcome despite the presence of a rich CD8+ T cell tumor infiltrate. This may be due to altera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eadcc79103364cb465b8581babf590e9
http://hdl.handle.net/11567/1052227
http://hdl.handle.net/11567/1052227
Autor:
Rui Wang, Rahul Karnik, Paul Zumbo, Olivier Elemento, Phillip Liu, Aristotelis Tsirigos, Giuseppina Astone, Doron Betel, Javier Rodriguez Hernaez, Akanksha Verma, Giorgio Inghirami, Michela Cumerlato, Luca Vincenzo Cappelli, Kirti Sharma, Liron Yoffe, Lara Brambilla, Jared Gollob, Steven M. Horwitz, Roberto Piva, Chris DeSavi, Joyoti Dey, David E. Levy, William Chiu, Francesco Boccalatte, Bin Yang, Clarisse Kayembe, Zachary D. Epstein-Peterson
Publikováno v:
Blood. 138:865-865
Introduction: Peripheral T-cell lymphomas (PTCLs) include heterogeneous entities of rare and aggressive neoplasms. The improved understanding of the biological/molecular mechanisms driving T-cell transformation and tumor maintenance has powerfully pr
Autor:
Luca Vincenzo Cappelli, Giuseppina Astone, Giorgio Inghirami, Wayne Tam, William Chiu, Maria Teresa Cacciapuoti, Giorgia Zanetti, Joseph M. Scandura, Lisa Giulino Roth, Danilo Fiore, Clarisse Kayembe, Lorenzo Galluzzi, Silvana Di Giandomenico
Publikováno v:
Blood. 138:2406-2406
Introduction: Immunotherapy is a promising therapeutic intervention for cancer treatment. Activation of the immune system via checkpoint blockade has been shown to produce antitumor responses in patients with both solid and hematological tumors. Howe